The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation to Canget BioTekpharma LLC for FL118, a drug candidate developed at Roswell Park Comprehensive Cancer Center, as a possible treatment for pancreatic cancer.

In recognition of his dedication toward advancements in lung cancer care as well as his contributions as a valued mentor, Roswell Park Comprehensive Cancer Center Chair of Thoracic Surgery, Sai Yendamuri, MD, MBA, FACS, has recently been honored with prestigious leadership roles, awards, and grant funding from both local and national organizations.

Following a national search, Roswell Park Comprehensive Cancer Center has selected George T. “Buddy” Hickman as its new Chief Digital & Information Officer. Hickman succeeds Tom Furlani, PhD, who retires this month.

Roswell Park Comprehensive Cancer Center has launched registration for the fourth annual IceCycle fundraising event, presented by the West Herr Automotive Group. This event is bringing together 13 WNY fitness studios and more than 1,000 participants on March 8 and 9 to take a 45-minute cycling class on ice while raising funds for research and programs at Roswell Park.